These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6852236)
21. Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents. Lown JW; Chen HH; Plambeck JA; Acton EM Biochem Pharmacol; 1979 Sep; 28(17):2563-8. PubMed ID: 229856 [No Abstract] [Full Text] [Related]
22. Protection by salvianolic acid A against adriamycin toxicity on rat heart mitochondria. Lin TJ; Liu GT; Liu Y; Xu GZ Free Radic Biol Med; 1992; 12(5):347-51. PubMed ID: 1317322 [TBL] [Abstract][Full Text] [Related]
23. Acute cardiovascular alterations induced by low doses of adriamycin, rubidazone, and daunorubicin in the anesthetized beagle dog. Herman EH; Young RS Cancer Treat Rep; 1979; 63(11-12):1771-9. PubMed ID: 526912 [TBL] [Abstract][Full Text] [Related]
24. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways. Jirkovsky E; Popelová O; Kriváková-Stanková P; Vávrová A; Hroch M; Hasková P; Brcáková-Dolezelová E; Micuda S; Adamcová M; Simůnek T; Cervinková Z; Gersl V; Sterba M J Pharmacol Exp Ther; 2012 Nov; 343(2):468-78. PubMed ID: 22915767 [TBL] [Abstract][Full Text] [Related]
25. Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats. Zbinden G; Brändle E Cancer Chemother Rep; 1975; 59(4):707-15. PubMed ID: 1175165 [TBL] [Abstract][Full Text] [Related]
26. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit. Jaenke RS; Deprez-DeCampeneere D; Trouet A Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026 [TBL] [Abstract][Full Text] [Related]
27. Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents. Bhuyan BK; Zimmer DM; Mazurek JH; Trzos RJ; Harbach PR; Shu VS; Johnson MA Cancer Res; 1983 Nov; 43(11):5293-7. PubMed ID: 6225515 [TBL] [Abstract][Full Text] [Related]
28. Spermine antagonizes the binding of adriamycin to the inner membrane of heart mitochondria. Solaini G Biochem Biophys Res Commun; 1989 Mar; 159(2):791-8. PubMed ID: 2930543 [TBL] [Abstract][Full Text] [Related]
29. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention. Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J Br J Pharmacol; 1996 Apr; 117(7):1593-9. PubMed ID: 8730759 [TBL] [Abstract][Full Text] [Related]
30. NADH oxidation in submitochondrial particles protects respiratory chain activity against damage by adriamycin-Fe3+. Demant EJ Eur J Biochem; 1983 Dec; 137(1-2):113-8. PubMed ID: 6317378 [TBL] [Abstract][Full Text] [Related]
31. Adriamycin and daunomycin semiquinone membrane/buffer partition constants using the spin-broadening technique. Alegría AE; Santiago G Arch Biochem Biophys; 1997 Oct; 346(1):91-5. PubMed ID: 9328288 [TBL] [Abstract][Full Text] [Related]
32. [Comparative evaluation of the cytogenetic action of anthracycline-group antitumor antibiotics (daunomycin, doxorubicin and carminomycin)]. Novitskiĭ VV; Klimova MIu; Gol'dberg ED Antibiot Med Biotekhnol; 1986 Oct; 31(10):765-8. PubMed ID: 3789686 [TBL] [Abstract][Full Text] [Related]
33. Influence of the structure of new anthracycline antibiotics on their biological properties. Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943 [TBL] [Abstract][Full Text] [Related]
34. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies. Henry-Toulme N; Stefanska B; Borowski E; Bolard J Mol Pharmacol; 1988 May; 33(5):574-9. PubMed ID: 3367905 [TBL] [Abstract][Full Text] [Related]
35. Electron spin resonance studies on the mechanism of adriamycin-induced heart mitochondrial damages. Ogura R; Sugiyama M; Haramaki N; Hidaka T Cancer Res; 1991 Jul; 51(13):3555-8. PubMed ID: 1647271 [TBL] [Abstract][Full Text] [Related]
36. Mitochondria-specific nano-emulsified therapy for myocardial protection against doxorubicin-induced cardiotoxicity. Faulk A; Weissig V; Elbayoumi T Methods Mol Biol; 2013; 991():99-112. PubMed ID: 23546663 [TBL] [Abstract][Full Text] [Related]
37. Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C. Kawasaki S; Akiyama S; Kurokawa T; Kataoka M; Dohmitsu K; Kondoh K; Yamauchi M; Ito K; Watanabe T; Sugiyama S Jpn J Cancer Res; 1992 Aug; 83(8):899-906. PubMed ID: 1399827 [TBL] [Abstract][Full Text] [Related]
39. Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin. Marcillat O; Zhang Y; Davies KJ Biochem J; 1989 Apr; 259(1):181-9. PubMed ID: 2719642 [TBL] [Abstract][Full Text] [Related]
40. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV. Nicolay K; de Kruijff B Biochim Biophys Acta; 1987 Jul; 892(3):320-30. PubMed ID: 3036220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]